Navigation Links
Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June
Date:4/9/2008

team is working diligently to gather the required information and prepare for the analysis and unblinding of the trial in June."

Favrille initiated its Phase 3 randomized, placebo-controlled, double-blind registration trial of Specifid for follicular B-cell NHL in July 2004. The Company completed enrollment in January 2006 with 349 patients randomized into the trial in a span of 18 months. The trial was open to both treatment-naive and previously treated patients, ultimately enrolling a much larger treatment-naive population (78%). Patients were randomized at a one-to-one ratio to receive either Specifid or placebo following a standard course of Rituxan. A total of 45 patients came off study and were permanently censored for reasons other than disease progression, 28 (8%) because Specifid was not produced and 17 (5%) for a variety of other reasons. The trial was conducted at 67 centers in the U.S. under a Special Protocol Assessment granted by the U.S. Food and Drug Administration (FDA). Specifid was also granted Fast Track status by the FDA in January 2006.

In October 2007 an independent Data Monitoring Board (DMB) conducted an administrative analysis of the unblinded control arm in the Phase 3 trial. The objective of this analysis, conducted in agreement with the FDA, was to assess the behavior of disease progression in the control arm in order to help determine the duration of follow-up needed prior to unblinding the trial. The outcome of this DMB analysis supported the rationale for the timing of data cutoff.

About Specifid

Specifid (mitumprotimut-T, formerly FavId) is a personalized, active immunotherapy designed to stimulate a patient's immune system to mount a specific and sustained response to the patient's cancer. Specifid is based upon a recombinant protein, called idiotype (Id), which is derived from genetic material obtained from a patient's own tumor, then conjugated to keyhole limpet hemocyanin (KLH), a protein commonly used
'/>"/>

SOURCE Favrille, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
2. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
3. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
4. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
5. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
6. Medarex Announces Ipilimumab Program Continues to Move Forward
7. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
8. CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
9. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
10. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
11. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014   Ventana Medical Systems, Inc. ... it has entered into an agreement with Merck KGaA, ... EMD Serono in the United States ... with Merck KGaA,s biopharmaceutical division on the development and ... target using Ventana,s proprietary diagnostic assays. In alignment with ...
(Date:7/10/2014)... R.I. , July 10, 2014 CVS Caremark ... board of directors has approved a quarterly dividend of $0.275 ... dividend is payable on August 1, 2014, to holders of ... CVS Caremark is dedicated to helping people ... pharmacy company in the United States . ...
(Date:1/15/2014)... DALLAS , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com ... to its store . (Photo: ... consumption upgrade and policy support, China,s ... the years, with total market size rising from 3.28 ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... ,, NEW YORK , May 17 Reportlinker.com announces that a ... , , ... , , ... This report analyzes the ...
... 17 CareFusion (NYSE: CFN ), a leading, global ... Medegen, a leading innovator in clinically differentiated needleless access connectors and administration ... in cash. , , ... CareFusion is an industry leader in IV infusion devices with its Alaris® ...
Cached Medicine Technology:Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 2Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 3Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 4Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 5Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 6Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 7Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 8Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 9Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 10Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 11Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 12Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 13Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 14Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 15Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 16Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 17Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 18Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 19Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 20Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 21Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 22Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 23Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 24Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 25Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 26Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 27Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 28Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 29Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 30Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 31CareFusion Completes Medegen Acquisition 2
(Date:7/10/2014)... In his latest blog post at ... CEO Per Wickstrom has listed 5 ways to follow-up ... an appointment, get information or sometimes even just return ... annoying is a skill that most people don’t have,” ... keep the dialogue moving without coming across as annoying ...
(Date:7/10/2014)... A Forever Recovery , an ... off to a great start and gives them a ... launched a new Eating Disorders section of its website ... , Different types of eating disorders ... Disorders (DSM-IV), including anorexia nervosa, bulimia nervosa, and EDNOS ...
(Date:7/10/2014)... July 10, 2014 Ivalua, the ... results of the 4th “Trending in Procurement” report ... , Every day multinational corporations process thousands ... forms etc. To meet this challenge, more and ... which can be defined as a suite of ...
(Date:7/10/2014)... the use of electronic health record becomes widespread across ... of the Affordable Care Act, the quantity of clinical ... purposes will also dramatically increase. Additionally, experts in ... analyze large quantities of data for the purpose of ... value of patient care a process that is ...
(Date:7/10/2014)... THURSDAY, July 10, 2014 (HealthDay News) -- Most professional ... to return to the game, a new study finds. ... players, but their rate of return after surgery to ... explained. The new study included 60 players who ... had this procedure successfully returned to play, defined as ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom’s Latest Blog Post Lists 5 Ways to Follow-up Without Being Annoying 2Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 3Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Shoulder Surgery Gets NFL Players Back in the Game 2
... Seahorse Bioscience, Inc., leader in the real-time ... XF96 Extracellular Flux Analyzer, the first analytical instrument ... and cytoplasmic glycolysis in a 96-well microplate, was ... Discovery Assays & Kits by researchers at the ...
... Electronic Medication Verification Will Help Eliminate Errors Like The ... During a highly emotional appearance on The ... Dennis Quaid warned that "computerized record-keeping and bar coding ... nearly killed his infant twins in 2007. While ...
... Professional Healthcare Resources, Inc., a home health and ... and Maryland, is pleased to announce that its ... Community Health Accreditation Program), the premier accrediting organization ... an in depth review of the company,s clinical ...
... Study found significant amount occurred in ICUs , , THURSDAY, ... are a major safety problem in intensive care units, ... 1,328 patients in 113 ICUs in 27 countries over ... with 50 patients were included in the study. , ...
... Race Organizers Anticipate Long-term Relationship with Esteemed Company , ... Tiffany & Co. will serve as the Awards Sponsor ... The event will be held on March 22, ... of the men,s and women,s marathon with a commemorative ...
... helps older Americans talk with their health care ... AARP today released Rx Snapshot , a ... help older family members, friends or neighbors manage ... ) The need is clear: 65 percent of ...
Cached Medicine News:Health News:Seahorse XF96 Extracellular Flux Analyzer Wins Best New Product Award for DRUG DISCOVERY at 2009 Molecular Medicine Conference 2Health News:The Detroit Medical Center Pioneers New EMR System Preventing Medication Mistakes 2Health News:The Detroit Medical Center Pioneers New EMR System Preventing Medication Mistakes 3Health News:The Detroit Medical Center Pioneers New EMR System Preventing Medication Mistakes 4Health News:The Detroit Medical Center Pioneers New EMR System Preventing Medication Mistakes 5Health News:Professional Healthcare's Hospice Program Receives CHAP Accreditation 2Health News:Injected Medication Errors a Major Problem 2Health News:Pasadena Marathon Presented By Kaiser Permanente Hails Partnership With Tiffany & Co. 2Health News:New AARP Initiative Encourages Community Members to Help Others Better Manage Their Prescriptions 2Health News:New AARP Initiative Encourages Community Members to Help Others Better Manage Their Prescriptions 3
... helps you deliver unmatched performance through patient-focused ... the most complete anesthesia solution developed, putting ... - at your fingertips., ,The Aisys ... legacy of anesthesia delivery and patient monitoring ...
... Premilene Mesh LP Self-Forming Plug is combining ... This results in a very soft hernia plug ... to standard Plugs less foreign body material is ... the hernia size and shape allows for a ...
... Celsius Control System provides physicians,with ... safely,and rapidly lower patient body ... temperature and,rewarm patients to normothermic ... consists of an endovascular,catheter, console ...
... Fiberoptics Gemini surgical headlight is perfectly balanced ... durable and ultra-low-profile and illuminates brilliantly while ... annoying "rams effect." The fully adjustable headband, ... to sit low on the brow, directing ...
Medicine Products: